Early bird registration is available for EACR members. 30% discount (academic institutions and pharma companies only).
Contact Danielle Dalby for details: firstname.lastname@example.org
Join 350 plus attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools. The 5th Annual Advances in Immuno-oncology Congress will showcase over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research.
Keywords: Immuno-oncology, immunotherapy, cancer genomics, biomarker, auto-immune, autoimmunity, immunology, personalised medicine, cancer immunology, cancer vaccines, oncology cell therapy, clinical oncology, oncology, CAR-T cell therapy
The EACR is grateful for the continued support of its Industry Partners: